Tilray Brands, Inc. ( TLRY) - Key Metrics
TLRY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $1.97 | -$0.39 | -$0.08 | -$0.08 |
| 2026Q1 | $2.71 | $0 | -$0.01 | -$0.01 |
| 2025Q4 | $3.15 | -$17.86 | -$0.20 | -$0.30 |
| 2025Q3 | $2.95 | -$12.55 | -$0.06 | -$0.27 |
TLRY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | -4.96 |
| 2026Q1 | ? | -827.00 |
| 2025Q4 | ? | -0.06 |
| 2025Q3 | ? | -0.15 |
TLRY
Price: $5.19
52 week price:
Earnings Per Share: -14.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 12.7 million
Market Capitalization: 691.9 million